Cable Forum - View Single Post

**Hugh** · 05-07-2020, 18:52

Quote:

Originally Posted by Sephiroth

Not that you were asking me, but who's gonna pay AZ the cost price for the vaccine for 3rd world countries?

Quote:

Originally Posted by Hugh

AZ, and various countries medical organisations are (during the pandemic) - investing in future customers...

Quote:

Originally Posted by Sephiroth

Woke, woke, woke. Ridiculous. AZ won't invest in the poor, oppressed (by their own regimes who should apologise immediately) in the third world, who have no chance of doing well for themselves in the way we're used to.

You better inform AZ about that, then...

Quote:

The Company has concluded the first agreements for at least 400 million doses and has secured total manufacturing capacity for one billion doses so far and will begin first deliveries in September 2020. AstraZeneca aims to conclude further agreements supported by several parallel supply chains, which will expand capacity further over the next months to ensure the delivery of a globally accessible vaccine.

AstraZeneca today received support of more than $1bn from the US Biomedical Advanced Research and Development Authority (BARDA) for the development, production and delivery of the vaccine, starting in the fall. The development programme includes a Phase III clinical trial with 30,000 participants and a paediatric trial.

In addition, the Company is engaging with international organisations such as the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance and the World Health Organisation (WHO), for the fair allocation and distribution of the vaccine around the world. AstraZeneca is also in discussions with governments around the world to increase access. Furthermore, AstraZeneca is in discussions with the Serum Institute of India and other potential partners to increase production and distribution....

... Financial considerations

Today’s announcement is not anticipated to have any significant impact on the Company’s financial guidance for 2020; expenses to progress the vaccine are anticipated to be offset by funding by governments.

https://www.astrazeneca.com/media-ce...no-profit.html

Quote:

The Company has recently completed similar agreements with the UK, US, the Coalition for Epidemic Preparedness Innovations and Gavi the Vaccine Alliance for 700 million doses, and it agreed a licence with the Serum Institute of India for the supply of an additional one billion doses, principally for low- and middle-income countries. Total manufacturing capacity currently stands at two billion doses.